Anuncio
Anuncio

SGRY

SGRY logo

Surgery Partners, Inc. Common Stock

15.91
USD
Patrocinado
+0.20
+1.30%
09 ene, 14:57 UTC -5
Apertura

Informes de beneficios de SGRY

Ratio de Sorpresa Positivo

SGRY superó 18 de las últimas 40 estimaciones.

45%

Próximo informe

Fecha del próximo informe
02 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
$883.74M
/
$0.32
Cambio implícito desde Q3 25 (Revenue/ EPS)
+7.58%
/
+146.15%
Cambio implícito desde Q4 24 (Revenue/ EPS)
+2.24%
/
-27.27%

Surgery Partners, Inc. Common Stock earnings per share and revenue

On 10 nov 2025, SGRY reported earnings of 0.13 USD per share (EPS) for Q3 25, missing the estimate of 0.16 USD, resulting in a -23.03% surprise. Revenue reached 821.50 millón, compared to an expected 837.45 millón, with a -1.90% difference. The market reacted with a -25.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analistas forecast an EPS of 0.32 USD, with revenue projected to reach 883.74 millón USD, implying an aumentar of 146.15% EPS, and aumentar of 7.58% in Revenue from the last quarter.
Preguntas frecuentes
For Q3 2025, Surgery Partners, Inc. Common Stock reported EPS of $0.13, missing estimates by -23.03%, and revenue of $821.50M, -1.9% below expectations.
The stock price moved down -25.42%, changed from $21.50 before the earnings release to $16.04 the day after.
The next earning report is scheduled for 02 mar 2026.
Based on 14 analistas, Surgery Partners, Inc. Common Stock is expected to report EPS of $0.32 and revenue of $883.74M for Q4 2025.
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio